3051 - 3075 of 8142 Results
Title
Year
- The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play2021RESTRICTEDTitle: The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of playJournal Name: British Journal of PharmacologyPublisher: WileyVol: 179Issue #: 8Start Page: 1478End Page: 1495Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bph.15575Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.15575Citation Count: 36
- Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease2021OPENTitle: Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s DiseaseJournal Name: Journal of Health Economics and Outcomes ResearchPublisher: The Journal of Health Economics and Outcomes ResearchVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.36469/001c.24620Best OA location URL: https://jheor.org/article/24620.pdfCitation Count: 6
- Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein2021OPENTitle: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synucleinJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429263Citation Count: 11
-
OPENTitle: Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD SamplesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.704041Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.704041/pdfCitation Count: 19
- Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab102021OPENTitle: Understanding LRRK2 kinase activity in preclinical models and human subjects through quantitative analysis of LRRK2 and pT73 Rab10Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-91943-4Best OA location URL: https://www.nature.com/articles/s41598-021-91943-4.pdfCitation Count: 47
- Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database2021OPENTitle: Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims DatabaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.571800Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.571800/pdfCitation Count: 23
- Evaluation of Individualized Multi‐Disciplinary Inpatient Treatment for Functional Movement Disorders2021OPENTitle: Evaluation of Individualized Multi‐Disciplinary Inpatient Treatment for Functional Movement DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 6Start Page: 911End Page: 918Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13268Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13268Citation Count: 16
- Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s Disease2021OPENTitle: Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington’s DiseaseJournal Name: Journal of Health Economics and Outcomes ResearchPublisher: The Journal of Health Economics and Outcomes ResearchVol: 8Issue #: 1Start Page: 99End Page: 105Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.36469/jheor.2021.24620Best OA location URL: https://jheor.org/article/24620.pdfCitation Count: 1
- Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by MAPT Variants2021OPENTitle: Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by MAPT VariantsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 6Start Page: 954End Page: 958Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13265Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13265Citation Count: 1
-
OPENTitle: Thyrotoxicosis Resulting in Unilateral Upper Limb Chorea and BallismusJournal Name: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences NeurologiquesPublisher: Cambridge University Press (CUP)Vol: 49Issue #: 3Start Page: 431End Page: 432Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/cjn.2021.136Citation Count: 3
- Correction to A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels2021RESTRICTEDTitle: Correction to A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium ChannelsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 16Issue #: 7Start Page: 1299End Page: 1300Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschembio.1c00368Citation Count: 2
-
OPENTitle: Freezing of gait and levodopaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 505End Page: 506Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00175-7Best OA location URL: http://www.thelancet.com/article/S1474442221001757/pdfCitation Count: 8
-
RESTRICTEDTitle: Frühzeichen der Parkinson-ErkrankungJournal Name: DGNeurologiePublisher: Springer Science and Business Media LLCVol: 4Issue #: 4Start Page: 295End Page: 303Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s42451-021-00352-4Citation Count: 0
-
OPENTitle: Prehospital scales in acute ischaemic stroke management – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 504End Page: 505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00169-1Best OA location URL: http://www.thelancet.com/article/S1474442221001691/pdfCitation Count: 1
- Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation2021OPENTitle: Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 157Issue #:Start Page: 105426End Page: 105426Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105426Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105426Citation Count: 8
- Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegeneration2021OPENTitle: Rare CASP6N73T variant associated with hippocampal volume exhibits decreased proteolytic activity, synaptic transmission defect, and neurodegenerationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-91367-0Best OA location URL: https://www.nature.com/articles/s41598-021-91367-0.pdfCitation Count: 12
- Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacy2021OPENTitle: Synergistic effects of autophagy/mitophagy inhibitors and magnolol promote apoptosis and antitumor efficacyJournal Name: Acta Pharmaceutica Sinica BPublisher: Elsevier BVVol: 11Issue #: 12Start Page: 3966End Page: 3982Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.apsb.2021.06.007Best OA location URL: https://doi.org/10.1016/j.apsb.2021.06.007Citation Count: 39
-
RESTRICTEDTitle: The Gastrointestinal Dysfunction Scale for Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2358End Page: 2366Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28675Citation Count: 14
- Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosis2021OPENTitle: Validity and reliability of the suggested immobilization test for measurement of restless legs syndrome severity in adults with multiple sclerosisJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 84Issue #:Start Page: 343End Page: 351Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.sleep.2021.06.005Best OA location URL: http://manuscript.elsevier.com/S1389945721003361/pdf/S1389945721003361.pdfCitation Count: 5
- Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients2021OPENTitle: Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease PatientsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1761End Page: 1772Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212694Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212694?id=journal-of-parkinsons-disease%2Fjpd212694Citation Count: 24
-
OPENTitle: In Silico Studies Comparing the Adjuvant Therapies Approved for Parkinson’s diseaseJournal Name: Journal of Drug Delivery and TherapeuticsPublisher: Society of Pharmaceutical TecnocratsVol: 11Issue #: 3-SStart Page: 104End Page: 110Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.22270/jddt.v11i3-s.4813Best OA location URL: http://jddtonline.info/index.php/jddt/article/download/4813/3895Citation Count: 1
- Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease2021OPENTitle: Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 7Start Page: 1456End Page: 1470Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51402Best OA location URL: https://hal.sorbonne-universite.fr/hal-03263514/file/acn3.51402.pdfCitation Count: 32
-
RESTRICTEDTitle: Novel Genes May Drive Progression in Parkinson's DiseaseJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 12Start Page: 25End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000756456.16968.c1Citation Count: 0
- Vagus Nerve and Stomach Synucleinopathy in Parkinson’s Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the “Body-First” Hypothesis2021OPENTitle: Vagus Nerve and Stomach Synucleinopathy in Parkinson’s Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the “Body-First” HypothesisJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1833End Page: 1843Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212733Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082635Citation Count: 60
- Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease2021OPENTitle: Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2303End Page: 2313Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28682Best OA location URL: https://www.research.unipd.it/bitstream/11577/3394074/1/MDS-36-2303.pdfCitation Count: 35